Blockchain Registration Transaction Record
AGC Biologics Partners with CompleCure to Develop Advanced Anti-Cancer Therapeutic Using Pioneering AMDC Technology
AGC Biologics partners with CompleCure to develop a novel anti-cancer therapeutic using AMDC technology, aiming to revolutionize breast cancer treatment and improve patient outcomes worldwide.
This news matters because it represents a significant advancement in cancer treatment, with the potential to revolutionize breast cancer therapy and improve patient outcomes. The collaboration between AGC Biologics and CompleCure could lead to the commercialization of a promising new treatment, ultimately contributing to the improvement of quality of life for cancer patients worldwide.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x9667f1a65df99ee4944a7fc157d5fe6a8d4241a1ba972cab2e26dbcc5410eb21 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | blurpxov-b402f601f2a0cbdd2da01583f0d61f81 |